Newsletter | August 21, 2026

08.21.26 -- Rewriting The Playbook For Stargardt Disease With Shannon Boye, Ph.D.

SPONSOR

PMWC 2027 Program Is Live

PMWC 2027: The program is live. Explore 15 focused programs spanning next-generation therapeutics, AI and computational medicine, precision diagnostics, and integrated precision medicine. Co-hosted by Stanford, UCSF, and Yale, PMWC features leaders including David Baker, Emmanuelle Charpentier, Andrew Ng, Fei-Fei Li, and Mary-Claire King, January 27-29, 2027, at the Santa Clara Convention Center.

FOCUS ON CLINICAL TRIALS

Rewriting The Playbook For Stargardt Disease With Shannon Boye, Ph.D.

Episode 134 of Cell & Gene: The Podcast features Host Erin Harris' discussion with Shannon Boye, PhD, Founder and CSO of Atsena Therapeutics. Dr. Boye shares how the company is approaching Stargardt disease with a differentiated gene therapy strategy built around delivery, dual-vector design, and a disciplined go/no-go framework.

Why RWD Strategy Can't Wait With Price, Value, And Evidence Pressures

Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

The Growing Complexity Of Conducting Oncology Trials

As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.

How Emerging Technologies Are Challenging Traditional IRB Oversight

Uncover how sponsors, CROs, and study monitors can navigate FDA expectations and Institutional Review Board (IRB) requirements when integrating AI and Software-as-a-Medical-Device into clinical trials.

Turning Around Trial Recruitment With Support

Through dedicated staffing, operational oversight, and collaboration with site teams, see how a struggling cardiology study was able to transform into a revitalized recruitment effort.

SPONSOR

11th CAR TCR Summit

Join the 11th CAR TCR Summit, the leading forum dedicated to advancing next generation cell therapies. Bringing together industry leaders, biopharma innovators, and clinical experts, this meeting explores manufacturing, clinical development, solid tumor strategies, and emerging approaches shaping the future of CAR T and TCR therapies.

CLINICAL TRIALS SOLUTIONS

Top 3 Tips For Choosing The Right Oncology CRO - Veristat, Inc.

Independent IRB Approval, Simplified - Univo IRB

FOCUS ON SUPPLY CHAIN

Supply Resiliency For Bioprocessing Amid Global Volatility

Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

Understanding The Cold Durability Performance Of Fluoropolymer Bags

Although polymer bags are an excellent choice for cold chain use, not all polymer films perform the same way, even if their specifications rate them for use at low temperatures.

Connect With Cell & Gene: